Enormous Myxoid/round Cell Liposarcoma: A Case Report

Overview

Journal Rare Tumors

Publisher Sage Publications

Specialty Oncology

Date 2024 May 20

PMID 38766573

Authors

Joshua R Finlay

Gayathri Vijayakumar

Ankica Braun

Abdullah Almajnooni

Austin Yu

Ira Miller

George Kokosis

Dian Wang

Alan Blank

Steven Gitelis

Affiliations

Soon will be listed here.

Abstract

Myxoid/round cell liposarcomas (MRCLPS) are a rare soft tissue sarcoma. We report the largest sarcoma in our institutional history. We discuss the patient's surgical management and treatment of the tumor and challenges given its dimensions. Several complications arose following primary resection that were managed by a multidisciplinary team. Although MRCLPS can vary in size, large MRCLPS must be treated cautiously given the potential for complications. Additionally, multidisciplinary treatment of MRCLPS is essential in diagnosing and treating these complex cases.

References

Lee A, Thway K, Huang P, Jones R . Clinical and Molecular Spectrum of Liposarcoma. J Clin Oncol. 2017; 36(2):151-159. PMC: 5759315. DOI: 10.1200/JCO.2017.74.9598. View

Durr H, Rauh J, Baur-Melnyk A, Knosel T, Lindner L, Roeder F . Myxoid liposarcoma: local relapse and metastatic pattern in 43 patients. BMC Cancer. 2018; 18(1):304. PMC: 5859402. DOI: 10.1186/s12885-018-4226-8. View

Orvieto E, Furlanetto A, Laurino L, Dei Tos A . Myxoid and round cell liposarcoma: a spectrum of myxoid adipocytic neoplasia. Semin Diagn Pathol. 2002; 18(4):267-73. View

Crago A, Dickson M . Liposarcoma: Multimodality Management and Future Targeted Therapies. Surg Oncol Clin N Am. 2016; 25(4):761-73. PMC: 5010855. DOI: 10.1016/j.soc.2016.05.007. View

Porrino J, Al-Dasuqi K, Irshaid L, Wang A, Kani K, Haims A . Update of pediatric soft tissue tumors with review of conventional MRI appearance-part 1: tumor-like lesions, adipocytic tumors, fibroblastic and myofibroblastic tumors, and perivascular tumors. Skeletal Radiol. 2021; 51(3):477-504. DOI: 10.1007/s00256-021-03836-2. View

Salduz A, Alpan B, Valiyev N, Ozmen E, Iribas A, Agaoglu F . Neoadjuvant radiotherapy for myxoid liposarcomas: Oncologic outcomes and histopathologic correlations. Acta Orthop Traumatol Turc. 2017; 51(5):355-361. PMC: 6197565. DOI: 10.1016/j.aott.2017.03.009. View

Davis A, OSullivan B, Bell R, Turcotte R, Catton C, Wunder J . Function and health status outcomes in a randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcoma. J Clin Oncol. 2002; 20(22):4472-7. DOI: 10.1200/JCO.2002.03.084. View

Moreau L, Turcotte R, Ferguson P, Wunder J, Clarkson P, Masri B . Myxoid\round cell liposarcoma (MRCLS) revisited: an analysis of 418 primarily managed cases. Ann Surg Oncol. 2011; 19(4):1081-8. DOI: 10.1245/s10434-011-2127-z. View

Nishida Y, Tsukushi S, Nakashima H, Ishiguro N . Clinicopathologic prognostic factors of pure myxoid liposarcoma of the extremities and trunk wall. Clin Orthop Relat Res. 2010; 468(11):3041-6. PMC: 2947684. DOI: 10.1007/s11999-010-1396-3. View

10.

Wu J, Qian S, Jin L . Prognostic factors of patients with extremity myxoid liposarcomas after surgery. J Orthop Surg Res. 2019; 14(1):90. PMC: 6438008. DOI: 10.1186/s13018-019-1120-2. View

11.

Davis A, OSullivan B, Turcotte R, Bell R, Catton C, Chabot P . Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma. Radiother Oncol. 2005; 75(1):48-53. DOI: 10.1016/j.radonc.2004.12.020. View

12.

Pawlik T, Delman K, Vauthey J, Nagorney D, Ng I, Ikai I . Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl. 2005; 11(9):1086-92. DOI: 10.1002/lt.20472. View

13.

Stranix J, Lee Z, Lam G, Mirrer J, Rapp T, Saadeh P . Limb-sparing sarcoma reconstruction with functional composite thigh flaps. Microsurgery. 2017; 38(5):466-472. DOI: 10.1002/micr.30254. View